Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-04-11
2006-04-11
Wax, Robert A. (Department: 1653)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600, C514S058000, C424S070130, C424S094600, C424S278100, C530S300000, C530S402000, C530S407000
Reexamination Certificate
active
07026288
ABSTRACT:
Disclosed are pharmaceutical compositions containing a cyclodextrin and a therapeutically effective amount of a glycopeptide antibiotic or a salt thereof. Also disclosed are methods of treating a bacterial disease in a mammal by administering such pharmaceutical compositions.
REFERENCES:
patent: 4639433 (1987-01-01), Hunt et al.
patent: 4643987 (1987-02-01), Nagarajan et al.
patent: 4698327 (1987-10-01), Nagarajan et al.
patent: 4727064 (1988-02-01), Pitha
patent: 4983586 (1991-01-01), Bodor
patent: 5024998 (1991-06-01), Bodor
patent: 5134127 (1992-07-01), Stella et al.
patent: 5324718 (1994-06-01), Loftsson
patent: 5376645 (1994-12-01), Stella et al.
patent: 5472954 (1995-12-01), Loftsson
patent: 5591714 (1997-01-01), Nagarajan et al.
patent: 5602112 (1997-02-01), Rubinfeld
patent: 5624914 (1997-04-01), Patel et al.
patent: 5750509 (1998-05-01), Malabarba et al.
patent: 5776912 (1998-07-01), Patel et al.
patent: 5804568 (1998-09-01), Rubinfeld
patent: 5840684 (1998-11-01), Cooper et al.
patent: 5874418 (1999-02-01), Stella et al.
patent: 5916873 (1999-06-01), Cooper et al.
patent: 5985310 (1999-11-01), Castillo et al.
patent: 6046177 (2000-04-01), Stella et al.
patent: 6048845 (2000-04-01), Rubinfeld
patent: 6620781 (2003-09-01), Linsell et al.
patent: 6635618 (2003-10-01), Leadbetter et al.
patent: 6770621 (2004-08-01), Linsell et al.
patent: 6828299 (2004-12-01), Yang et al.
patent: 2002/0077280 (2002-06-01), Judice et al.
patent: 2003/0078371 (2003-04-01), Mu
patent: 2003/0207797 (2003-11-01), Leadbetter et al.
patent: 2004/0063916 (2004-04-01), Leadbetter et al.
patent: 2004/0087494 (2004-05-01), Linsell et al.
patent: 2004/0229775 (2004-11-01), Linsell et al.
patent: 1 222 697 (1987-06-01), None
patent: 0 094 157 (1983-11-01), None
patent: 0 335 545 (1989-10-01), None
patent: 0 463 653 (1992-01-01), None
patent: 0 667 353 (1995-08-01), None
patent: 0 149 197 (1997-01-01), None
patent: 0 816 378 (1998-01-01), None
patent: 82/00251 (1982-02-01), None
patent: 94/12217 (1994-06-01), None
patent: 94/20136 (1994-09-01), None
patent: 95/06485 (1995-03-01), None
patent: WO 98/55148 (1998-12-01), None
patent: WO 00/39156 (2000-07-01), None
patent: WO 00/54751 (2000-09-01), None
patent: WO 00/59528 (2000-10-01), None
patent: WO 01/83520 (2001-11-01), None
patent: WO 01/97851 (2001-12-01), None
patent: WO 01/98326 (2001-12-01), None
patent: WO 01/98327 (2001-12-01), None
patent: WO 01/98328 (2001-12-01), None
patent: WO 01/98329 (2001-12-01), None
U.S. Appl. No. 10/931,122, Judice et al.
Allen et al., “The Role of Hydrophobic Side Chains as Determinants of Antibacterial Activity of Semisynthetic Glycopeptide Antibiotics”, The Journal of Antibiotics, vol. 50, No. 8, pp 677-684 (1997).
Ge et al., “Vancomycin Derivatives That Inhibit Peptidoglycan Biosynthesis Without Binding D-Ala-D-Ala”, SCIENCE, vol. 284, pp 507-511 (1999).
Nagarajan et al., “Synthesis and Antibacterial Evaluation of N-Alkyl Vancomycins”, The Journal of Antibiotics, vol. XLII, No. 1, pp 63-72 (1989).
Nicolaou et al., “Chemistry, Biology, and Medicine of the Glycopeptide Antibiotics”, Angew Chem. Int. Ed., 38, pp 2096-2152 (1999).
Pavlov et al., “A New Type of Chemical Modification of Glycopeptides Antibiotics: Aminomethylated Derivaties of Eremomycin and Their Antibacterial Activity”, The Journal of Antibiotics, vol. 50, No. 6, pp 509-513 (1997).
Pavlov et al., Chemical Modification of Glycopeptide Antibiotics [VC1], Russian Journal of Bioorganic Chemistry, vol. 24, No. 9, pp 570-587(1998).
Pavlov et al., “Mono and Double Modified Teicoplanin Aglycon Derivatives on the Amino Acid No. 7; Structure-activity Relationship”, The Journal of Antibiotics, vol. 51, No. 1, pp 73-78 (1998).
Pea et al., “High vancomycin dosage regimens required by intensive care unit patients cotreated with drugs to improve haemodynamics following cardiac surgical procedures”, Journal of Antimicrobial Chemotherapy, 45, pp 329-335 (2000).
Uekama et al., “Protective effects of cyclodextrin sulphates against gentamicin-induced nephrotoxicity in the rat”, J. Pharm. Pharmacol.., 45, pp 745-747 (1993).
Zhang et al., “A review of recent applications of cyclodextrins for drug discovery”, Exp. Opin. Ther. Patents, 9(12), pp 1697-1717 (1999).
Toyoguchi et al., “Nephrotoxicity of Vancomycin and Durg Interaction Study with Cilastatin in Rabbits,” Antimicrob. Agents Chemother., 1997, 41(9). 1985-1990.
Conner Michael W.
Judice J. Kevin
Mu YongQi
Pace John L.
Shaw Jeng Pyng
Hagenah Jeffrey A.
Liu Samuel W.
Theravance Inc.
Wax Robert A.
LandOfFree
Pharmaceutical compositions containing a glycopeptide... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions containing a glycopeptide..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions containing a glycopeptide... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3539742